Please note:
An
erratum has been published for this article. To view the erratum, please
click here.
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notice to Readers: Recommended Adult Immunization Schedule ---
United States, 2003--2004
In June 2003, the Advisory Committee on Immunization Practices (ACIP) approved the revised Adult
Immunization Schedule for 2003--2004. The format has been revised to better represent the schedule's two components, by age group and by medical condition (Figures
1 and 2) and better indicate how the footnotes apply to both figures.
Revisions to the schedule and footnotes include 1) additional information regarding use of tetanus-diphtheria toxoids
as prophylaxis in wound management; 2) clarification regarding the number of doses of the measles component of the measles-mumps-rubella vaccine; 3) guidance regarding the use of intranasally administered, live, attenuated influenza vaccine for healthy persons aged 5--49 years; 4) recommendations regarding administering influenza vaccination to pregnant women
with or without pre-existing chronic diseases or conditions; and 5) added information regarding influenza and consideration of Haemophilus influenzae type b vaccine for asplenic persons.
Two measures initiated by the Centers for Medicare and Medicaid Services (CMS) are expected to increase
vaccination among Medicare and Medicaid beneficiaries. First, in 2002, CMS enacted a new regulation allowing for the use of standing orders at Medicare- and Medicaid-participating hospitals, long-term--care facilities, and home-health agencies to deliver influenza and pneumococcal vaccinations
(1) as recommended by ACIP (2) and the Task Force on Community
Preventive Services (3). Second, CMS increased reimbursement rates for administering hepatitis, influenza, and pneumococcal vaccines from a national average of $3.98 in 2002 to $7.72 in 2003
(4). In addition, expansion of the National Committee for
Quality Assurance's Health Plan Employer Data and Information Set to include quality indicators on influenza vaccinations for persons aged 50--64 years in 2001 and pneumococcal vaccinations for persons aged
>65 years in 2002 might improve vaccination-delivery services at managed-care organizations
(5,6).
Health-care providers are reminded they should administer influenza vaccinations to all persons aged
>50 years, regardless of preexisting medical conditions
(7). Family physicians, internists, obstetrician/gynecologists, and other providers in
private practice are urged to use the Adult Immunization Schedule in conjunction with the Standards for Adult Immunization Practices (8). Evidence indicates that chart
reminders, patient reminders/recalls, and standing orders will reduce
missed opportunities to vaccinate (9,10).
General information regarding adult immunization and vaccinating immunosuppressed persons can be obtained from state and local health departments and from CDC's National Immunization Program at
http://www.cdc.gov/nip. The
2003--2004 Adult Immunization Schedule is available at
http://www.cdc.gov/nip/recs/adult-schedule.htm. Vaccine information statements are available at
http://www.cdc.gov/nip/publications/vis. ACIP statements for each recommended vaccine are available at
http://www.cdc.gov/nip/publications/acip-list.htm. In addition, instructions for reporting adverse events after vaccination to the Vaccine Adverse Event Reporting System are available at
http://www.vaers.org or by telephone, 800-822-7967.
References
U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. Medicare and Medicaid programs; conditions of participation: immunization standards for hospitals, long-term care facilities, and home health agencies. Federal Register
2002;67:61808--14. Available at
http://www.cms.gov/providerupdate/regs/cms3160fc.pdf.
Task Force on Community Preventive Services. Recommendations
regarding interventions to improve vaccination coverage in children,
adolescents, and adults. Am J Prev Med 2000;18(suppl):92--140.
Centers for Medicare & Medicaid Services. 2003 administration rate allowances. Baltimore, Maryland: Centers for Medicare and Medicaid Services, 2003. Available at
http://www.cms.hhs.gov/preventiveservices/2.asp.
Ahmed F, Harris J, Shih S, Pawlson G. New HEDIS performance measure on influenza immunization for 50- to 64-year-old adults. Prev
Med Manag Care 2001;2:215--21.
Ahmed F, Elbasha EE, Thompson BL, Harris JR, Sneller VP. Cost-benefit analysis of a new HEDIS performance measure for
pneumococcal vaccination. Med Decis Making 2002;22(suppl):S58--S66.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
